Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Clinical trial NCT01275222 · COMPLETED
Trial details
- NCT number
- NCT01275222
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-13
- Primary completion
- 2008-09-03
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.